Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tariquidar with Chemotherapy and Surgery for Adrenocortical Cancer
NCT00071058Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Oct 2003
- Primary completion
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of tariquidar in adrenocortical carcinoma (ACC), sponsored by National Cancer Institute. Primary endpoint: Percentage of Participants With a Partial or Complete Response. Started Oct 2003; status: completed.
02
Drugs
tariquidar
03
Conditions
adrenocortical carcinoma (ACC)
Beyond the preview
Go deeper on NCT00071058.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00071058.